Related Experiment Video
Updated: May 31, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold
Melissa M Kemp1, Qiu Wang, Jason H Fuller
1Broad Institute of Harvard and MIT, Cambridge, MA 02142, United States.
None:
Histone deacetylases (HDACs) are enzymes involved in many important biological functions. They have been linked to a variety of cancers, psychiatric disorders, and other diseases. Since small molecules can serve as probes to study the relevant biological roles of HDACs, novel scaffolds are necessary to develop more efficient, selective drug candidates. Screening libraries of molecules may yield structurally diverse probes that bind these enzymes and modulate their functions in cells. Here we report a small molecule with a novel hydroxy-pyrimidine scaffold that inhibits multiple HDAC enzymes and modulates acetylation levels in cells. Analogs were synthesized in an effort to evaluate structure-activity relationships.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Antiviral Nucleoside Inhibitors
Inhibition of CDK Activity
Inhibition of Cdk Activity
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial DNA Synthesis

